Hesperos, Inc. (HESP)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	n/a
Revenue (ttm)	5.11M
Net Income (ttm)	-773,316
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About HESP

Hesperos, Inc. is a socially-conscious company that uses our non-invasive, serum-free, multi-organ chip platform (Human-on-a-Chip) systems to provide pre-clinical analytical services with the goal of accelerating drug discovery and general toxicology testing and reducing use of animal testing. Our Human-on-a-Chip platform system mimics the process of initial patient evaluation during a clinical trial, where functional human in vitro tissues are evaluated similar to a patient undergoing medical testing to determine baseline performance metrics. ...

• Industry: Health Care
• Sector: Life Sciences Tools & Services
• Founded: 2015
• Employees: 27
• Stock Exchange: NASDAQ
• Ticker Symbol: HESP
• Website: https://hesperosinc.com/